e-learning
resources
Virtual 2020
Pre-Congress Content
Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Russian IPF Registry: time of inclusion impacts patients’ status
S. Chikina (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), I. Tyurin (Moscow, Russian Federation), A. Cherniak (Moscow, Russian Federation), Z. Merzhoeva (Moscow, Russian Federation)
Source:
Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session:
Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session type:
E-poster session
Number:
1842
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Chikina (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), I. Tyurin (Moscow, Russian Federation), A. Cherniak (Moscow, Russian Federation), Z. Merzhoeva (Moscow, Russian Federation). Russian IPF Registry: time of inclusion impacts patients’ status. 1842
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Association of COPD stages and comorbidities in Italian general practices: The COMODHES study
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD)
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020
Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021
Year: 2021
Health status and gender predict time to next exacerbation in patients with COPD
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Clinical description of a population of Dutch IPF patients
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021
Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016
Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF)
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Impact of age in the clinical expression of COPD in Greek patients
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Health status and utility for COPD patients: a questionnaire-based study
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007
Health status comparison of patients with COPD throughout the world: the BOLD Initiative
Source: Eur Respir J 2006; 28: Suppl. 50, 450s
Year: 2006
Health status changes in Dutch regular care COPD patients classified per GOLD category
Source: International Congress 2018 – Primary care management of COPD
Year: 2018
Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC)
Source: Eur Respir J 2002; 20: Suppl. 38, 262s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept